CHOSA Oncology AB’s postpones publication of the interim report Q2
CHOSA Oncology announced today, 27th August 2023, the decision to postpone the release of its interim report for the second quarter of 2023. The previously communicated publication date of Monday, August 28, 2023, will be rescheduled to Thursday, August 31, 2023.
The company's performance throughout the second quarter has aligned with expectations and remains in accordance with the established financial plan. Operations have been executed in line with projections, and current funding is secured through the second quarter of 2024. The delay in publishing the quarterly report is attributed solely to unforeseen administrative circumstances that fall beyond the scope of the Company's control.
This disclosure contains information that Chosa Oncology AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 27-08-2023 18:51 CET.
